Wolverine Asset Management LLC Invests $181,000 in NewAmsterdam Pharma (NASDAQ:NAMSW)

Wolverine Asset Management LLC purchased a new position in NewAmsterdam Pharma (NASDAQ:NAMSW) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 12,693 shares of the company’s stock, valued at approximately $181,000.

NewAmsterdam Pharma Price Performance

Shares of NAMSW opened at $8.00 on Tuesday. The company has a 50 day moving average price of $11.88 and a 200-day moving average price of $9.85. NewAmsterdam Pharma has a fifty-two week low of $5.52 and a fifty-two week high of $16.75.

NewAmsterdam Pharma Profile

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases.